IDiyas

For the Inventor, By the Inventor

Singen, Germany

Angelika Esswein

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 69(Granted Patents)


Location History:

  • Singen, DE (1996 - 1999)
  • Buttelbron, DE (2000)
  • Büttelbron, DE (2002)
  • Büttleborn, DE (2004)
  • Büttelborn, DE (2001 - 2005)

Company Filing History:

goldMedal6 out of 480 
 
Roche Diagnostics Gmbh
 patents
silverMedal4 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
bronzeMedal2 out of 832,680 
Other
 patents

Years Active: 1996-2005

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6911553 - Osteoblast-specific mitogens and drugs containing such compounds (2005-06-28),
2. 6673816 - Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders (2004-01-06),
3. 6472396 - Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds (2002-10-29),
4. 6444832 - Amino alcohol derivatives, method of producing said derivatives and medicaments containing them (2002-09-03),
5. 6429288 - Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds (2002-08-06),
6. 6197759 - Osteoblast-specific mitogens and drugs containing such compounds (2001-03-06),
7. 6110924 - Barbituric acid derivatives, processes for their production and (2000-08-29),
8. 5972947 - Oxazolidinone derivatives, processes for the production thereof and (1999-10-26),
9. 5698541 - 2,4-diphosphonoglutaric acid derivatives, processes for their production (1997-12-16),
10. 5683994 - Phosphosuccinic acid derivatives, processes for the production thereof (1997-11-04),
11. 5627170 - Phosphonic acid compound containing heterocyclic substituents, (1997-05-06),
12. 5538957 - Phosphonosuccinic acid derivatives, processes for their preparation and (1996-07-23),

Title: Angelika Esswein: Innovator in Bone Metabolic Disorder Treatments

Introduction

Angelika Esswein is a prominent inventor based in Singen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bone metabolic disorders. With a total of 12 patents to her name, her work has had a profound impact on medical science.

Latest Patents

Among her latest patents is a groundbreaking invention related to osteoblast-specific mitogens and drugs containing such compounds. This invention focuses on compounds of a specific formula that can be metabolized in vivo to yield effective treatments for bone metabolic disorders. Another notable patent involves rhodanine carboxylic acid derivatives, which are designed for the treatment and prevention of metabolic bone disorders. These compounds also follow a specific formula and include various physiologically compatible forms that can be utilized in medical applications.

Career Highlights

Throughout her career, Angelika has worked with renowned companies such as Roche Diagnostics GmbH and Boehringer Mannheim GmbH. Her experience in these organizations has allowed her to develop innovative solutions that address critical health issues.

Collaborations

Angelika has collaborated with notable professionals in her field, including Christos Tsaklakidis and Lothar Kling. These partnerships have further enhanced her research and development efforts.

Conclusion

Angelika Esswein's contributions to the field of pharmaceuticals, particularly in the treatment of bone metabolic disorders, highlight her innovative spirit and dedication to improving health outcomes. Her extensive patent portfolio reflects her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…